US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
Вам также может понравиться
Растущие активы
Последние новости криптовалют
AI News Today: Когда ИИ встречает блокчейн, возможности, которые нельзя упустить
Ethereum погружается ниже $2900
SOL Short-Term Price Drops Below $130
Powell Resignation Rumor Surfacing Again? Выступит с речью во вторник утром
A certain whale went 10x long on HYPE, with a position value exceeding $19 million, and a liquidation price of $25.724
Служба поддержки:@weikecs
Деловое сотрудничество:@weikecs
Количественная торговля и ММ:[email protected]
VIP-программа:[email protected]